Literature DB >> 26115798

The place of PD-1 inhibitors in melanoma management.

Samantha Bowyer1, Paul Lorigan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26115798     DOI： 10.1016/S1470-2045(15)00094-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  Long noncoding RNA MHENCR promotes melanoma progression via regulating miR-425/489-mediated PI3K-Akt pathway.

Authors:  Xiangjun Chen; Hao Dong; Sha Liu; Li Yu; Dexiong Yan; Xingwei Yao; Weijing Sun; Dezhi Han; Guozhen Gao
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

2.  IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors.

Authors:  Michael J Allegrezza; Melanie R Rutkowski; Tom L Stephen; Nikolaos Svoronos; Amelia J Tesone; Alfredo Perales-Puchalt; Jenny M Nguyen; Fahmida Sarmin; Mee R Sheen; Emily K Jeng; Julia Tchou; Hing C Wong; Steven N Fiering; Jose R Conejo-Garcia
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

Review 3.  Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.

Authors:  Md Mominur Rahman; Tapan Behl; Md Rezaul Islam; Md Noor Alam; Md Mohaimenul Islam; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Simona Gabriela Bungau
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

4.  Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma.

Authors:  Xiangjun Chen; Guozhen Gao; Sha Liu; Li Yu; Dexiong Yan; Xingwei Yao; Weijing Sun; Dezhi Han; Hao Dong
Journal:  Biomed Res Int       Date:  2017-02-07       Impact factor: 3.411

5.  Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy.

Authors:  Lin Cong; Qiaofei Liu; Ronghua Zhang; Ming Cui; Xiang Zhang; Xiang Gao; Junchao Guo; Menghua Dai; Taiping Zhang; Quan Liao; Yupei Zhao
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.